Minerva Neurosciences, Inc (NERV) Financials
NERV Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 56.9 billion | 85.4 billion |
2023-09-30 | 63.1 million | 83.2 million |
2023-06-30 | 67.1 million | 79.6 million |
2023-03-31 | 51.6 million | 78.2 million |
NERV Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -6.0 million | 611064 |
2023-09-30 | -6.9 million | 371943 |
2023-06-30 | -3.9 million | 608915 |
2023-03-31 | -115407 | 376459 |
NERV Net Income
No data available :(
NERV Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 40.9 billion | - | - |
2023-09-30 | 46.9 million | - | - |
2023-06-30 | 51.8 million | - | - |
2023-03-31 | 36.0 million | - | - |
NERV Shares Outstanding
NERV Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 4.7 million | 2.5 million | -7746 |
2023-09-30 | - | 3.4 million | 2.6 million | - |
2023-06-30 | - | 1.9 million | 2.6 million | - |
2023-03-31 | - | 2.7 million | 2.7 million | - |
NERV Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 7746 |
2023-09-30 | - | 7745 |
2023-06-30 | - | 7746 |
2023-03-31 | - | 7745 |
NERV
Price: $2.37
52 week price:
Payout Ratio Range:
Earnings Per Share: -4.61 USD
P/E Ratio: -1.89
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 48300
Ebitda: -11.1 millionMarket Capitalization: 17.8 million